- PT2020

SPEF

Designation of the project | R&D projects: SPEF - Surface Plasmon Resonance enhanced fluorescence

Approval date | 19-04-2016
Start date | 01-01-2016
Data de conclusão | 31-12-2017
Custo total elegível | 1 002 826,75€
EU Financing | 401 130,70€5€

Project summary
The present proposal aims at the development of an innovative high-performance Point of Care testing product, leveraging on biosurfit' s Intellectual Property and accumulated knowhow, to implement Surface Plasmon Resonance enhanced fluorescence (SPEF) detection in spinit® products. These activities will gain from established processes and infra-structure at biosurfit and will merge into a major integration validation activity using two clinically relevant panels in Cardiology and Endocrinology.

Strategic goals

• Make the spinit® technology a global solution being one of the top players in the PoC diagnostic market; 
• Attract intelligent and international strategic investment to maintain national production and generate investment; 
• Create and develop an R&D and manufacture centre with a specialized team contributing to the country’s development and supporting the launch of new projects at the diagnostics market; 
• Continuously invest in technological innovation with annual submission of at least 3 new international patents to solve existing technical problems, contributing to a reduction of costs and improvement of diagnostic performance;
• Actively participate in the preposition of the companion diagnostics and assisted living with remote clinical monitoring, through the development and launch in the market of diagnostic solutions with high performance and reduced investment for the end users and their integration with the health systems;

Designation of the project | R&D projects: SPEF - Surface Plasmon Resonance enhanced fluorescence
Project Code | ALT20-03-0247-FEDER-011135;
Main goal | Reinforce research, technology development and innovation
Region of activity | Alentejo
Beneficiary | biosurfit S.A.

Approval date | 19-04-2016
Start date | 01-01-2016
End Date | 31-12-2017
Total eligible value | 492 311,30€
EU Financing | 352 732,13€

Project summary
The present proposal aims at the development of an innovative high-performance Point of Care testing product, leveraging on biosurfit' s Intellectual Property and accumulated knowhow, to implement Surface Plasmon Resonance enhanced fluorescence (SPEF) detection in spinit® products. These activities will gain from established processes and infra-structure at biosurfit and will merge into a major integration validation activity using two clinically relevant panels in Cardiology and Endocrinology.

Strategic goals

• Make the spinit® technology a global solution being one of the top players in the PoC diagnostic market;

• Attract intelligent and international strategic investment to maintain national production and generate investment;

• Create and develop an R&D and manufacture centre with a specialized team contributing to the country’s development and supporting the launch of new projects at the diagnostics market;

• Continuously invest in technological innovation with annual submission of at least 3 new international patents to solve existing technical problems, contributing to a reduction of costs and improvement of diagnostic performance;

• Actively participate in the preposition of the companion diagnostics and assisted living with remote clinical monitoring, through the development and launch in the market of diagnostic solutions with high performance and reduced investment for the end users and their integration with the health systems;